SBI Securities’s scPharmaceuticals SCPH Stock Holding History

SBI Securities’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-486	Closed	-$2.76K	–	4189
2025 Q3	$2.76K	Sell	486 -102	-17%	-$522	﹤0.01%	2301
2025 Q2	$2.24K	Sell	588 -49	-8%	-$152	﹤0.01%	2335
2025 Q1	$1.68K	Buy	637 +340	+114%	+$1.11K	﹤0.01%	2366
2024 Q4	$1.05K	Buy	+297	New	+$1.14K	﹤0.01%	2586

SBI Securities's SCPH Position: Q4 2025 in Review

SBI Securities sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 486 shares — an estimated $2.76K sold.

SBI Securities first reported a position in SCPH in Q4 2024 and held it in 4 quarters. The position peaked at $2.76K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

SBI Securities reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 486 scPharmaceuticals shares in Q4 2025, an estimated $2.76K.
SBI Securities first reported a position in scPharmaceuticals in Q4 2024 and held it in 4 quarters.
SBI Securities's scPharmaceuticals position peaked at $2.76K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.